All Type of News
H&B and drug stores reaching about 1,700 stores in Korea
It has been 20 years since CJ(CheilJedang at the time) opened the first Olive Young store as a drug store in 1999. There are now about 1,700 H&B(Health & Beauty) and drug stores in Korea.
Currently, there are 1,173 O...
Korean Pharmaceutical Association being active top stop Restriction-Free Zone Act
Korean Pharmaceutical Association Chairman Chan-Hwi Cho visited the National Assembly on the 24 to take actions to stop the Service Industry Development Act and the Restriction-Free Zone Act that destroy the people’s ...
Daewoong Chairman Jae-Seung Yoon, “I’ll take a step out of the management for careless words and actions”
Daewoong Pharmaceutical Chairman Jae-Seung Yoon announced to step out of his position for the issue he created with his words and actions.
“For the YTN’s repot about my words and actions, I deeply apologize to everyo...
MOHW starts to select innovative pharmaceutical companies for the 4th time
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) and the Korea Health Industry Development Institute announced on the 27th that they would take applications for ‘innovative pharmaceutical company’ bet...
How did listed pharmas with operating profits?
KOSDAQ listed pharmaceutical companies had a significantly higher operating profit rate on average than KOSPI listed pharmaceutical companies in the first half of this year.
Yakup Shinmoon(www.yakup.com) analyzed 38 ...
Shin Poong Pharm signs ‘MEDICURTAIN’ supply agreement with Serbian ‘EMI Pharm’
Shin Poong Pharm(CEO Jae-Man Yoo) signed a supply agreement of the anti-adhesion barrier MEDICURTAIN with EMI Pharm D.O.O.
Shin Poong Pharm said the company will exclusively supply MEDICURTAIN in Serbia and Montenegr...
JW Pharmaceutical exports new Atopic dermatitis therapy technology to LEO Pharma
JW Pharmaceutical(CEO Jae-Kwang Jeon & Young-Sup Shin) announced on the 24th that they signed a license-out agreement of its innovative Atopic dermatitis therapy ‘JW1601’ with LEO Pharma(CEO Gitte Aabo) having special...
4 listed pharma including Seoul Pharma spend more than 50% of their sales into SG&A
One of 3 listed pharmaceutical companies reportedly send 40% of their sales into selling, general and administrative(SG&A) expenses. Particularly, 4 companies, such as Seoul Pharma, Jin Yang Pharmaceutical, Korea Arli...
Health care providers’ distrust on generics due to Valsartan incident, switching to originals
As carcinogenic N-nitrosodimethylamine is detected in Valsartan ingredients from Chinese and Indian one after another, part of the medical field is researched to prescribe the original drug more.
On the 27th, ‘InterM...
Will the drug serial number system be enforced next January?
It seems there is a high chance for the drug serial number system to be enforced as expected after the administrative grace period at the end of this month.
Recently, Health and Welfare Minister Neung-Hoo Park has sh...
